| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 4, 2005
Accepted on January 30, 2006
Department of Zoology, The University of Hong Kong, Pokfulam Road, Hong Kong
* To whom correspondence should be addressed. E-mail: awong1{at}hku.hk.
The expression of hepatocyte growth factor (HGF) receptor, encoded by the Met oncogene, is elevated in ovarian and a variety of cancers. Here, we show that human ovarian cancer cells with high Met expression were more sensitive to the cell motility and invasion effect of HGF. Met downregulation by small interfering RNAs or K252a resulted in reduced migration in response to HGF. The invasive/migratory phenotype activated by HGF can be blocked by specific inhibitors of the PI3K (phosphatidylinositol-3-kinase) cascade, by inhibitor of p70S6K and also by the expression of a dominant negative Akt, demonstrating that HGF transmits the motogenic signal through PI3K and Akt to p70S6K. A significant role for p70S6K in cell invasion is further supported by the observation that expression of constitutively active forms of p70S6K is sufficient to induce invasive and migratory phenotypes in ovarian cancer cells. Importantly, activation of p70S6K stimulated expression and proteolytic activity of matrix metalloproteinase (MMP)-9 and cellular invasion while it had little effect on MMP-2, suggesting for the first time that MMP-9 up-regulation by p70S6K as a key step for HGF-induced invasion and migration. These data suggest that interfering p70S6K may provide a novel means of controlling tumor cell invasiveness.
This article has been cited by other articles:
![]() |
H. Jin, R. Yang, Z. Zheng, M. Romero, J. Ross, H. Bou-Reslan, R. A.D. Carano, I. Kasman, E. Mai, J. Young, et al. MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival Cancer Res., June 1, 2008; 68(11): 4360 - 4368. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kong, S. Banerjee, W. Huang, Y. Li, Z. Wang, H.-R. C. Kim, and F. H. Sarkar Mammalian Target of Rapamycin Repression by 3,3'-Diindolylmethane Inhibits Invasion and Angiogenesis in Platelet-Derived Growth Factor-D-Overexpressing PC3 Cells Cancer Res., March 15, 2008; 68(6): 1927 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ye, D. Hu, L. Tu, X. Zhou, F. Lu, B. Wen, W. Wu, Y. Lin, Z. Zhou, and J. Qu Involvement of PI3K/Akt Signaling Pathway in Hepatocyte Growth Factor-Induced Migration of Uveal Melanoma Cells Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Zhou, Y. L. Pon, and A. S. T. Wong Synergistic Effects of Epidermal Growth Factor and Hepatocyte Growth Factor on Human Ovarian Cancer Cell Invasion and Migration: Role of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase Endocrinology, November 1, 2007; 148(11): 5195 - 5208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W.T. Cheung, P. C.K. Leung, and A. S.T. Wong Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9. Cancer Res., November 15, 2006; 66(22): 10902 - 10910. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |